Teriflunomide shifts the astrocytic bioenergetic profile from oxidative metabolism to glycolysis and attenuates TNFα-induced inflammatory responses

[1]  A. Schousboe,et al.  Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration , 2021, Neuropharmacology.

[2]  Kira E. Poskanzer,et al.  Reactive astrocyte nomenclature, definitions, and future directions , 2021, Nature Neuroscience.

[3]  A. Nebreda,et al.  Diversity and versatility of p38 kinase signalling in health and disease , 2021, Nature Reviews Molecular Cell Biology.

[4]  M. Kopf,et al.  Redox regulation of immunometabolism , 2020, Nature Reviews Immunology.

[5]  M. Sofroniew.  Astrocyte Reactivity: Subtypes, States, and Functions in CNS Innate Immunity. , 2020, Trends in immunology.

[6]  M. Mattson,et al.  Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing , 2020, Nature Reviews Drug Discovery.

[7]  Jiahuai Han,et al.  An overview of mammalian p38 mitogen-activated protein kinases, central regulators of cell stress and receptor signaling , 2020, F1000Research.

[8]  T. Oron,et al.  Astrocyte senescence promotes glutamate toxicity in cortical neurons , 2020, PloS one.

[9]  L. Samavati,et al.  MAP kinase phosphatase-1, a gatekeeper of the acute innate immune response. , 2019, Life sciences.

[10]  A. Bar-Or,et al.  Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects , 2019, Science Translational Medicine.

[11]  E. Zimmer,et al.  The astrocyte biochemistry. , 2019, Seminars in cell & developmental biology.

[12]  Leming Shi,et al.  Mitochondrial dysfunction induced by leflunomide and its active metabolite. , 2018, Toxicology.

[13]  Tala Bakheet,et al.  ARED-Plus: an updated and expanded database of AU-rich element-containing mRNAs and pre-mRNAs , 2017, Nucleic Acids Res..

[14]  S. Rahman,et al.  Unveiling some FDA-approved drugs as inhibitors of the store-operated Ca2+ entry pathway , 2017, Scientific Reports.

[15]  M. P. Pinheiro,et al.  The dihydroorotate dehydrogenases: Past and present. , 2017, Archives of biochemistry and biophysics.

[16]  L. Galluzzi,et al.  The spectrum of T cell metabolism in health and disease , 2017, Nature Reviews Immunology.

[17]  Michael D. Buck,et al.  Metabolic Instruction of Immunity , 2017, Cell.

[18]  J. Rathmell,et al.  A guide to immunometabolism for immunologists , 2016, Nature Reviews Immunology.

[19]  J. Bolaños.  Bioenergetics and redox adaptations of astrocytes to neuronal activity , 2016, Journal of neurochemistry.

[20]  E. Chang,et al.  Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse , 2016, Neuron.

[21]  C. Lucchinetti,et al.  NFκB signaling drives pro-granulocytic astroglial responses to neuromyelitis optica patient IgG , 2015, Journal of Neuroinflammation.

[22]  S. Biswas.  Metabolic Reprogramming of Immune Cells in Cancer Progression. , 2015, Immunity.

[23]  N. Sousa,et al.  From the periphery to the brain: Lipocalin-2, a friend or foe? , 2015, Progress in Neurobiology.

[24]  Y. Fragoso,et al.  Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases , 2015, Expert review of clinical pharmacology.

[25]  M. Sofroniew.  Astrocyte barriers to neurotoxic inflammation , 2015, Nature Reviews Neuroscience.

[26]  E. Cadenas,et al.  Astrocytic metabolic and inflammatory changes as a function of age , 2014, Aging cell.

[27]  S. Sollott,et al.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. , 2014, Physiological reviews.

[28]  A. Bar-Or,et al.  Teriflunomide and Its Mechanism of Action in Multiple Sclerosis , 2014, Drugs.

[29]  Andreas Meisel,et al.  Sugar for the brain: the role of glucose in physiological and pathological brain function , 2013, Trends in Neurosciences.

[30]  J. Rathmell,et al.  Metabolic regulation of T lymphocytes. , 2013, Annual review of immunology.

[31]  Pierre J. Magistretti,et al.  Oligodendroglia metabolically support axons and contribute to neurodegeneration , 2012, Nature.

[32]  Y. Iwamoto,et al.  Liposomal clodronate selectively eliminates microglia from primary astrocyte cultures , 2012, Journal of Neuroinflammation.

[33]  Seda Genc,et al.  Astrocyte - neuron lactate shuttle may boost more ATP supply to the neuron under hypoxic conditions - in silico study supported by in vitro expression data , 2011, BMC Systems Biology.

[34]  Mark H. Ellisman,et al.  Development of a Method for the Purification and Culture of Rodent Astrocytes , 2011, Neuron.

[35]  J. Rathmell,et al.  The metabolic life and times of a T‐cell , 2010, Immunological reviews.

[36]  H. Ichijo,et al.  The roles of ASK family proteins in stress responses and diseases , 2009, Cell Communication and Signaling.

[37]  A. Schousboe,et al.  Functional significance of brain glycogen in sustaining glutamatergic neurotransmission , 2009, Journal of neurochemistry.

[38]  P. Whitton,et al.  Microglial cells in astroglial cultures: a cautionary note , 2007, Journal of Neuroinflammation.

[39]  Liang Peng,et al.  Energy Metabolism in Astrocytes: High Rate of Oxidative Metabolism and Spatiotemporal Dependence on Glycolysis/Glycogenolysis , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[40]  M. Beal,et al.  Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases , 2006, Nature.

[41]  J. Inoue,et al.  Recruitment of Tumor Necrosis Factor Receptor-associated Factor Family Proteins to Apoptosis Signal-regulating Kinase 1 Signalosome Is Essential for Oxidative Stress-induced Cell Death* , 2005, Journal of Biological Chemistry.

[42]  S. Manna,et al.  Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression. , 1999, Journal of immunology.

[43]  R. Williamson,et al.  Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. , 1998, The Biochemical journal.

[44]  Kohei Miyazono,et al.  Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1 , 1998, The EMBO journal.

[45]  Minoru Takagi,et al.  Induction of Apoptosis by ASK1, a Mammalian MAPKKK That Activates SAPK/JNK and p38 Signaling Pathways , 1997, Science.

[46]  R. Kerr.  A cautionary note. , 1988, Science.

[47]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[48]  B. Beutler,et al.  Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[49]  R. Siegel,et al.  Extracellular flux analysis to monitor glycolytic rates and mitochondrial oxygen consumption. , 2014, Methods in enzymology.

[50]  A. Schousboe,et al.  Glutamate metabolism in the brain focusing on astrocytes. , 2014, Advances in neurobiology.

[51]  H. Cherwinski,et al.  The immunosuppressant leflunomide inhibits lymphocyte progression through cell cycle by a novel mechanism. , 1995, The Journal of pharmacology and experimental therapeutics.

[52]  A. J. Linenthal,et al.  Past and present. , 1987, The Pharos of Alpha Omega Alpha-Honor Medical Society. Alpha Omega Alpha.